Sharon E. Underberg - 14 Feb 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
EVP, GC & Corp. Secretary
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg
Issuer symbol
IDXX
Transactions as of
14 Feb 2022
Net transactions value
-$127,899
Form type
4
Filing time
16 Feb 2022, 18:29:47 UTC
Next filing
18 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +483 +25% $0.000000 2,402 14 Feb 2022 Direct F1
transaction IDXX Common Stock Options Exercise $0 +217 +9% $0.000000 2,619 14 Feb 2022 Direct
transaction IDXX Common Stock Options Exercise $0 +138 +5.3% $0.000000 2,757 14 Feb 2022 Direct
transaction IDXX Common Stock Tax liability $127,899 -253 -9.2% $505.53 2,504 14 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award +5,917 5,917 14 Feb 2022 Common Stock 5,917 $505.53 Direct F2, F8
transaction IDXX Incentive Stock Option (right-to-buy) Award +197 197 14 Feb 2022 Common Stock 197 $505.53 Direct F3, F8
transaction IDXX Restricted Stock Unit Award +692 +26% 3,341 14 Feb 2022 Common Stock 692 Direct F4, F8
transaction IDXX Restricted Stock Unit Options Exercise -483 -14% 2,858 14 Feb 2022 Common Stock 483 Direct F5, F8
transaction IDXX Restricted Stock Unit Options Exercise -217 -7.6% 2,641 14 Feb 2022 Common Stock 217 Direct F6, F8
transaction IDXX Restricted Stock Unit Options Exercise -138 -5.2% 2,503 14 Feb 2022 Common Stock 138 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 40.9949 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021.
F2 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023.
F3 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.
F4 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
F7 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F8 Not applicable.